Personal Economics
  • Exclusive - India's Lupin, U.S. firms weigh bids for GSK's mature drugs: sources

    Exclusive - India's Lupin, U.S. firms weigh bids for GSK's mature drugs: sources

    By Sophie Sassard and Zeba Siddiqui, Reuters

    LONDON/MUMBAI (Reuters) - Indian generics firm Lupin <LUPN.NS>, some U.S. drugmakers looking for a tax-saving deal in Europe and private equity funds are planning to bid for a range of older...

  • Detroit workers, retirees give bankruptcy plan a boost

    Detroit workers, retirees give bankruptcy plan a boost

    By Karen Pierog and Lisa Lambert, Reuters

    (Reuters) - Detroit will head into the critical phase of its historic bankruptcy case next month with the backing of an overwhelming majority of its active and retired workers and with opposition...

  • Verizon revenues top estimates on wireless surge

    Verizon revenues top estimates on wireless surge

    By Marina Lopes, Reuters

    (Reuters) - Verizon Communications Inc, the largest U.S. wireless telecommunications company, on Tuesday reported better-than-expected quarterly revenue on a jump in wireless customers and a surge in...

  • Why Your MRI or CT Scan Costs An Arm and a Leg

    By Lacie Glover, The Fiscal Times

    Medical imaging is one of the most common diagnostic techniques used today, and by far the costliest, but the good news is that you can curb spending on medical imaging, which is employed to diagnose...

  • The Best and Worst States for a Life Well-Lived

    By John Grgurich, The Fiscal Times

    How long can a baby born today in Missouri, New Mexico, or Minnesota expect to live? What wages and salaries are typical of Latinos in the United States, and how do they compare to those of whites or...